5 Stocks, 5 Different Industries, 1 Thing in Common: Reliable Income

Diversifying income across genuinely uncorrelated cash-flow engines is more powerful than owning five versions of the same defensive stock. The five names below span biopharma, semiconductors, package delivery and waste management services, and their cash flows respond to completely different drivers: patent cliffs, chip cycles, freight volumes and municipal disposal contracts. The shared hook is durability. To frame the range, United Parcel Service (NYSE:UPS | UPS Price Prediction) carries a 6.54% dividend yield at the high end while Waste Management sits at 1.62% at the low end, and every name in between is a proven cash generator.

AbbVie: Immunology Cash Flow Funding a Growing Payout

AbbVie (NYSE:ABBV) currently yields 2.63% on an annual dividend of $6.83 per share, with the board having declared a $1.73 quarterly payment that puts the annualized forward dividend at $6.92.

Safety comes from the immunology franchise now anchoring results. Second-quarter revenue was nearly $17 billion, up 10.2%, with Skyrizi at $5.5 billion (up 24%) and Rinvoq above $2.5 billion (up 23.7%) more than covering Humira erosion. Management raised full-year adjusted EPS guidance to $13.87 to $14.07 and pointed to “strong cash flows, balance sheet, and business outlook” supporting the payout. The dividend history shows successive annual bumps from $1.41 in 2022 to $1.48, $1.55, $1.64 and $1.73 through 2026, a consistent raise pattern since the 2013 spin-off.

Bull case: Skyrizi and Rinvoq are structurally accelerating, the Skyrizi composition-of-matter patent runs through 2033, and management continues to layer on deals like the $10.9 billion Apogee Therapeutics acquisition to extend the pipeline.

Risk: leverage is elevated after buybacks pushed book equity negative, and management is targeting a two-times net leverage ratio within two to three years of the Apogee close. Pipeline hiccups would tighten dividend headroom.

Merck: KEYTRUDA Cash Plus a Commitment to Raise

Merck (NYSE:MRK) yields 2.31% on an annual dividend of $3.32 per share. The current quarterly is 85 cents, up from 81 cents in the 2024 to 2025 cycle and 77 cents the year before, an annual raise cadence that stretches back through the visible record.

The safety story starts with KEYTRUDA. Keytruda family sales rose 4% to $8.4 billion in the quarter, and CFO Caroline Litchfield said directly, “We remain committed to the dividend with the goal of increasing it over time.” Full-year non-GAAP revenue guidance sits at $66.3 billion to $67.3 billion, and Merck is on pace for approximately $3 billion in share repurchases this year alongside the dividend.

Bull case: CEO Robert Davis framed the loss-of-exclusivity risk plainly, calling the LOE “more of a hill than a cliff” and expecting “a shallow dip with a fast return back to growth.” The pipeline supporting that view includes a stated commercial opportunity “greater than $70 billion” from over 20 new products. Shares have run hard, up more than 38% year to date (YTD) as of midday Sept. 17, and more than 81% over the past year, so income buyers are paying up for the reset.

Risk: The KEYTRUDA patent transition is real, and GARDASIL weakness in China shows how quickly a franchise can move against Merck. A slower ramp on new launches would compress coverage during the transition.

Texas Instruments: Analog Cash Machine in Cycle Upturn

Texas Instruments (NASDAQ:TXN) yields 2.19% on an annual dividend of $5.62 per share. The current quarterly is $1.42, raised from $1.36 in the 2024 and early 2025 records and $1.30 in 2024, extending a long visible pattern of annual increases stretching back through 38 cents in 2016.

Coverage is improving fast because the analog cycle turned. Second-quarter revenue was $5.5 billion, up 23% year over year, with operating profit at $2.3 billion, or 42% of revenue, up 48% year-over-year. Trailing 12-month free cash flow reached $6.5 billion, up from $1.8 billion in the second quarter of 2025, and TXN paid $1.3 billion in dividends during the quarter. Management repeated its “commitment to return all free cash flow to shareholders.” The balance sheet holds $7 billion of cash and short-term investments against $14 billion of debt.

Bull case: CEO Haviv Ilan told analysts, “I think we are in the start of a cycle that is very, very broad,” with industrial up around 30% year on year and data-center revenue doubled year-over-year. The 300mm build-out is largely funded, freeing more free cash flow to fund the dividend as capex normalizes toward the $2 to $3 billion guided range.

Risk: semiconductor cyclicality cuts both ways. Shares are already up 46.38% YTD, and a stall in industrial or auto demand would slow the free-cash-flow rebuild that the dividend growth model depends on.

UPS: Ultra-High-Yield With a Transformation Overhang

United Parcel Service is the ultra-high-yield name in the group at 6.54%, on an annual dividend of $6.56 per share. Investors need to understand what that yield reflects: the quarterly has been $1.64 across seven consecutive ex-dates from February 2025 through August 2026, so the streak is currently a hold rather than a fresh raise after the small move from $1.63 in 2024 to $1.64 in 2025.

The coverage math is tightening but still workable. Full-year 2026 guidance calls for adjusted diluted EPS of approximately $7.22, free cash flow of approximately $5.5 billion, and planned dividends of around $5.4 billion, subject to Board approval. Consolidated Q2 revenue was $22.8 billion, up 7.6%, with U.S. domestic operating margin up 100 basis points year-over-year and 400 basis points from the first quarter. UPS ended the quarter with $4.7 billion in cash and no outstanding commercial paper.

Bull case: The deliberate Amazon glide-down. Management removed approximately 2 million pieces per day of lower-quality Amazon volume and approximately $4.5 billion of related expense, calling the reconfiguration “a leaner, more automated, more agile network that will deliver operating leverage as volume grows.” Revenue per piece rose 9.3% year over year as mix shifted toward SMB and healthcare.

Risk: The dividend consumes nearly all guided free cash flow before the pension contribution, so any hiccup in the volume recovery or another quarter of heavy transformation charges would put the payout under fresh scrutiny.

Waste Management: Boring Cash Flow, Reliable Raises

Waste Management (NYSE:WM) yields 1.78% on an annual dividend of $3.54 per share, with the current quarterly at 94 cents and an annualized forward dividend of $3.78. The dividend record shows steady annual increases: 75 cents quarterly in 2024, 82 cents in 2025 and 94 cents in 2026, with a continuous quarterly payment history extending back to 1999.

This is the most boring cash-flow profile in the group, which is the point. Q2 free cash flow was $1.10 billion, up 34.5% year over year, and first-half free cash flow reached $2.02 billion, growing more than 56%. Full-year guidance calls for FCF of $3.75 to $3.85 billion against total first-half returns of $1 billion in buybacks and $764 million in dividends. Leverage finished the quarter at 2.96 times, within the targeted range of 2.5x to 3x.

Bull case: Pricing power meeting automation. Core price was expected to exit 2026 above 5.5%, collection cost growth was held to less than 1.7% despite roughly 4% labor cost inflation, and recycling plus renewable energy operating EBITDA grew nearly 33%.

Risk: this is a low-growth income name. Shares are down 2.93% YTD, volumes ran -1.8% and Stericycle integration still carries costs. The tradeoff sits in the total-return contribution from price.

Putting the Basket Together

Five industries, five distinct cash-flow engines, one shared attribute: each business generates enough operating cash to fund a dividend that has been raised on a regular cadence in the visible record. AbbVie and Merck lean on immunology and oncology franchises. Texas Instruments is riding the analog upcycle back to full free-cash-flow conversion. UPS offers the highest yield with the tightest coverage and Waste Management provides the steadiest, most defensive payout of the group.

If you want to extend this basket toward names with 50-plus-year raise streaks, we ranked ten of them by valuation in a free Dividend Kings report. Own them together and a patent setback, a chip downturn, a freight slowdown, or a bad recycling commodity year cannot take down the income stream at the same time.

Contact [email protected] for any questions or corrections.